Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
32.99
+1.51 (4.80%)
At close: Jul 20, 2026, 4:00 PM EDT
32.50
-0.49 (-1.49%)
Pre-market: Jul 21, 2026, 7:46 AM EDT
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $2.03 billion as of July 21, 2026. Its market cap has increased by 42,714.26% in one year.
Market Cap
2.03B
Enterprise Value
1.50B
1-Year Change
42,714.26%
Ranking
Category
Stock Price
$32.99
ChartMarket Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $2.03B, an increase of 450.64%. That is a compound annual growth rate of 34.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 2.03B | 5,424.90% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 1.99B |
| AbCellera Biologics | 1.97B |
| GH Research | 1.97B |
| Ocular Therapeutix | 1.96B |
| Lakefront Biotherapeutics NV | 1.96B |
| UroGen Pharma | 1.96B |
| Harmony Biosciences Holdings | 1.96B |
| Nanobiotix | 1.91B |